Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully co...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Allergan
NCT06481475 · Moderate to Severe Glabellar Lines
NCT06205797 · Glabellar Lines
NCT07321834 · Glabellar Lines
NCT06583486 · Moderate to Severe Glabellar Lines
NCT07398755 · Glabellar Lines, Midface Volume Deficiency, and more
Newport Beach, California
Vancouver, British Columbia
Antibes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions